Quote:
Originally Posted by VictimOfDHT
Oh thank God, another FUTURE treatment. Man, we have dozens upon dozens of potential FUTURE treatments that the present never seems to catch up with.
|
I understand your frustration but I don't think you can lump CB in with all those other stagnant treatments. There are very few hair loss drugs actually actively being developed, which is something Cosmo have pointed out in some of their presentations.
If you take out the snake oil and just look at drugs actually in clinical trials there is pretty much just Latisse and Avodart I think. And after what's happening with Fin I have my doubts Avodart will ever be seriously marketed for hair loss, since it's even more potent than Fin. Astressin-B is supposed to be starting clinical trials soon, and then there is ASC-J9 and CB-03-01. ASC doesn't seem to be going anywhere fast which is a pity because it could be a very powerful drug against MPB.
And that's pretty much it as far as I'm aware. The others, RU, NEOSH etc, I don't think will ever be developed. We should be grateful that in Cosmo we have a company that is apparently interested in pushing ahead with a drug for MPB, because that seems to be what's really been lacking. Of course it may still fall by the wayside like so many others have, but at least it's not being sat on by an uninterested company while the patent expires.
But I know what you mean. I won't really believe in CB-03-01 until I have the first bottle in my hand.